Comments
Chelsea's hypotension drug fails to prove efficacy past week one
05.12.2012. | (Reuters) - Chelsea Therapeutics Inc said its experimental hypotension drug met the main goal of a study by significantly reducing dizziness in patients at week one, but results beyond that period were not statistically significant....
